| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/01/2011 | EP2326644A1 Urotensin ii receptor antagonists |
| 06/01/2011 | EP2326643A2 Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| 06/01/2011 | EP2326642A2 Salt of, and processes for the preparation of, 1-isopropyl-4-{[4-(tetrahydro-2h-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1h-1,4-diazepine |
| 06/01/2011 | EP2326641A2 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 06/01/2011 | EP2326640A1 Pyrrole carboxylic acid derivatives as antibacterial agents |
| 06/01/2011 | EP2326639A1 Substituted pyridines, and use thereof as gsk3 inhibitors |
| 06/01/2011 | EP2326638A1 Diazepine and diazocane compounds as mc4 agonists |
| 06/01/2011 | EP2326637A2 Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium |
| 06/01/2011 | EP2326636A2 Pyrazole carboxamide inhibitors of factor xa |
| 06/01/2011 | EP2326635A1 Novel substituted sulfamide derivatives |
| 06/01/2011 | EP2326634A1 Chromene modulators of chemokine receptor activity |
| 06/01/2011 | EP2326633A1 Compounds for the treatment of hepatitis c |
| 06/01/2011 | EP2326632A2 Novel choline cocrystal of epalrestat |
| 06/01/2011 | EP2326629A1 Sulfone compounds which modulate the cb2 receptor |
| 06/01/2011 | EP2326628A1 Azo-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 06/01/2011 | EP2326627A1 Substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 06/01/2011 | EP2326626A1 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
| 06/01/2011 | EP2326625A1 Benzazepine derivatives and their use as hstamine h3 antagonists |
| 06/01/2011 | EP2326623A2 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
| 06/01/2011 | EP2326622A1 Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds |
| 06/01/2011 | EP2326621A1 SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS |
| 06/01/2011 | EP2326619A2 Methionine analogs and methods of using same |
| 06/01/2011 | EP2326618A1 Glucagon antagonists |
| 06/01/2011 | EP2326334A2 Methods for treating bleeding disorders |
| 06/01/2011 | EP2326333A1 Agent for promoting neuronal differentiation and method therefor |
| 06/01/2011 | EP2326332A1 Method for treatment of diseases |
| 06/01/2011 | EP2326330A1 Compositions for treating or delaying the onset of hair loss |
| 06/01/2011 | EP2326329A1 Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine |
| 06/01/2011 | EP2326328A1 Use of dihydralazine for the treatment of diseases related to elevated semicarbazide sensitive amine-oxidase (ssao) activity |
| 06/01/2011 | EP2326327A2 Analogs of indole-3-carbinol and their use as agents against infection |
| 06/01/2011 | EP2326326A2 Purin derivatives for use in the treatment of fab-related diseases |
| 06/01/2011 | EP2326325A1 Compounds for the treatment of peripheral neuropathies |
| 06/01/2011 | EP2326324A1 Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack |
| 06/01/2011 | EP2326323A1 Compositions comprising terpene compounds for treating negative sensory phenomena |
| 06/01/2011 | EP2326322A1 Novel crystal form of calcium-3-acetyl aminopropane-1-sulfonate |
| 06/01/2011 | EP2326321A1 Taurine or taurine-like substances for the prevention of brain oedema |
| 06/01/2011 | EP2326320A1 2, 4-disulfonyl pheny tert-butyl nitrone for the treatment of gliomas |
| 06/01/2011 | EP2326319A1 Conjugated suramin amino compounds for medical conditions |
| 06/01/2011 | EP2326318A2 Sur1 inhibitors for therapy |
| 06/01/2011 | EP2326317A1 Guanylhydrazones for treatment of postoperative intestinal inflammation |
| 06/01/2011 | EP2326316A1 Sustained release compositions comprising gums and sugar alcohols |
| 06/01/2011 | EP2326315A1 Treatment of an autoimmune disease using il-18 antagonists |
| 06/01/2011 | EP2326313A1 Ph-dependent controlled release pharmaceutical composition for non-opioids with resistance against the influence of ethanol |
| 06/01/2011 | EP2326312A1 Paliperidone composition comprising solid matrix particles |
| 06/01/2011 | EP2326311A1 Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof |
| 06/01/2011 | EP2326310A1 Gastric retentive pharmaceutical compositions for treatment and prevention of cns disorders |
| 06/01/2011 | EP2326309A2 Improvements relating to nanodisperse compositions |
| 06/01/2011 | EP2326306A1 Liquid formulations of bendamustine |
| 06/01/2011 | EP2326182A1 Composition and method to modify sperm fertility and female gender ratio in mammals |
| 06/01/2011 | EP2326181A1 Antifungal agents |
| 06/01/2011 | EP2326180A1 Antifungal agents |
| 06/01/2011 | EP2326179A1 Prolyl hydroxylase inhibitors |
| 06/01/2011 | EP2326177A1 3- and 6-quinolines with n-attached heterocyclic cgrp receptor antagonists |
| 06/01/2011 | EP2326176A1 Non-amidic linkers with branched termini as cgrp receptor antagonists |
| 06/01/2011 | EP2326175A2 Allosteric enhancers of the a1 adenosine receptor |
| 06/01/2011 | EP2326174A1 Hdac4, hdac5, hdac6, hdac7, and hif1 alpha modulation of retinal cell survival |
| 06/01/2011 | EP2245006B1 Sulfonamides as orexin antagonists |
| 06/01/2011 | EP2183260B1 Phosphadiazine hcv polymerase inhibitors iv |
| 06/01/2011 | EP2129378B1 Therapeutic compositions comprising thromboserin or a salt thereof for use in the prevention or treatment of thrombosis in a patient at risk of bleeding |
| 06/01/2011 | EP2114913B1 Thiophene derivatives useful as ocular hypotensive agents |
| 06/01/2011 | EP2099796B1 Aza-indolyl compounds and methods of use |
| 06/01/2011 | EP1904060B1 Use of phthalocyanine derivates for the non-photodynamic treatment of diseases |
| 06/01/2011 | EP1838716B1 Olanzapine pamoate dihydrate |
| 06/01/2011 | EP1785484B1 Oligonucleotide inhibiting tumor cell proliferation and method therefor |
| 06/01/2011 | EP1716135B1 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists |
| 06/01/2011 | EP1622914B1 New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 06/01/2011 | EP1585470B1 Transdermal delivery of fentanyl |
| 06/01/2011 | EP1584925B1 Novel screening method |
| 06/01/2011 | EP1386608B1 Remedial agent for glomerular disease |
| 06/01/2011 | EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers |
| 06/01/2011 | EP1337525B1 Process for the crystallization of (r)- or (s)-lansoprazole |
| 06/01/2011 | EP1169314B2 Process for the manufacture of salts of citalopram |
| 06/01/2011 | DE202011003362U1 Zusammensetzung, insbesondere dermatologische Salbe Composition, notably a dermatological ointment |
| 06/01/2011 | DE202010007433U1 Gel, insbesondere Gleitgel Gel, especially Lube |
| 06/01/2011 | DE112009000268T5 Prasugrel-Salze mit verbesserten Eigenschaften Prasugrel salts with improved properties |
| 06/01/2011 | DE102010002558A1 Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe The use of physiological cooling agents and compositions comprising such agents |
| 06/01/2011 | DE102004009952B4 Verfahren zur Erkennung von Sepsis A method for the detection of sepsis |
| 06/01/2011 | CN1997370B Use of n-sulfamoyl-n'-arylpiperazines in preparing medicine for the prophylaxis or treatment of obesity and related conditions |
| 06/01/2011 | CN1989090B Cis-1,2-substituted diphenyl ethylene derivatives and its use in preparing medine for treating and/or preventing diabetes |
| 06/01/2011 | CN1953977B Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof |
| 06/01/2011 | CN1950353B Materials and methods for treating coagulation disorders |
| 06/01/2011 | CN1934103B Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
| 06/01/2011 | CN1927201B Antibiotic compound recipe comprising piperacillin |
| 06/01/2011 | CN1911924B Extraction method of Nepal eagle tail isoflavone, its derivative and medicipal composition using said derivative as active component |
| 06/01/2011 | CN1893837B Serum remnant-like lipoprotein concentration regulator |
| 06/01/2011 | CN1875016B Imidazole derivatives |
| 06/01/2011 | CN102083849A Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
| 06/01/2011 | CN102083847A Novel nucleic acid transfer system |
| 06/01/2011 | CN102083845A Cyclopropyl polymerase inhibitors |
| 06/01/2011 | CN102083841A Novel class of spiro piperidines for the treatment of neurodegenerative diseases |
| 06/01/2011 | CN102083840A Antitumoral macrolides |
| 06/01/2011 | CN102083839A Compounds |
| 06/01/2011 | CN102083835A Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-A]pyrimidines, methods for preparation and uses thereof |
| 06/01/2011 | CN102083834A 7H-indolo[2,1-a] [2] benzazepine-10-carboxylic acid derivatives for the treatment of hepatitis c |
| 06/01/2011 | CN102083833A Substituted quinazolines as blood platelet lowering agents |
| 06/01/2011 | CN102083831A Naphthyridininones as AURORA kinase inhibitors |
| 06/01/2011 | CN102083830A Pyrido [3, 4-b] indoles and methods of use |
| 06/01/2011 | CN102083829A Improved Raf inhibitors |
| 06/01/2011 | CN102083828A Heterocyclic compounds and compositions as C-KIT and PDGFR kinase inhibitors |
| 06/01/2011 | CN102083827A Thiazolidine compounds as orexin receptor antagonists |